Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
1983.
COMMUNICATIONS.
British Journal of Pharmacology,
Vol. 78,
Issue. S1,
Eccleston, D.
Fairbairn, A. F.
Hassanyeh, F.
McClelland, H. A.
and
Stephens, D. A.
1985.
The Effect of Propranolol and Thioridazine on Positive and Negative Symptoms of Schizophrenia.
British Journal of Psychiatry,
Vol. 147,
Issue. 6,
p.
623.
Hornykiewicz, Oleh
1986.
Vol. 65,
Issue. ,
p.
29.
de Bonis, Monique
de Boeck, Paul
and
Lebeaux, Marie-Odile
1987.
Problèmes méthodologiques posés par la classification des formes de schizophrénie: recherche de corrélations ou de relations d'appartenance?.
Psychiatry and Psychobiology,
Vol. 2,
Issue. 3,
p.
174.
Meltzer, H. Y.
1987.
Clinical Pharmacology in Psychiatry.
p.
255.
Kemali, Dargut
Maj, Mario
Galderisi, Silvana
Ariano, Maria Grazia
and
Starace, Fabrizio
1990.
Factors associated with increased noradrenaline levels in schizophrenic patients.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 14,
Issue. 1,
p.
49.
Möller, H.-J.
1993.
Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties.
European Neuropsychopharmacology,
Vol. 3,
Issue. 1,
p.
1.
Möller, H.-J.
and
Rao, M. L.
1996.
Implications of Psychopharmacology to Psychiatry.
p.
158.
Gorriti, Miguel Angel
Rodrı́guez de Fonseca, Fernando
Navarro, Miguel
and
Palomo, Tomás
1999.
Chronic (−)-Δ9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
European Journal of Pharmacology,
Vol. 365,
Issue. 2-3,
p.
133.
Ordieres, María Graciela López
2019.
Psychiatry and Neuroscience Update.
p.
417.
eLetters
No eLetters have been published for this article.